| Molecular formula | C45H55N9O6 |
| Molecular weight | 818 g/mol |
| Registered trials | 0 |
| PubChem CID | 6918245 |
What GHRP-2 Is
GHRP-2 is a synthetic peptide compound identified in chemical databases under PubChem CID 6918245, with a molecular formula of C45H55N9O6 and a molecular weight of approximately 818. It has no FDA-approved label and is not authorized for any medical use in the United States. GHRP-2 remains classified as an unapproved research compound, meaning it has not completed the review process required for approval and carries no sanctioned indications, dosing guidance, or safety labeling.
Regulatory and Trial Status
As an unapproved research compound, GHRP-2 has not been evaluated by regulators for safety or effectiveness in any population. No registered clinical trials for GHRP-2 currently appear in available trial databases, and no sample trial records are available to summarize. This absence of registered trials means there is no public clinical trial record to draw on for this compound at this time.
FAQ
No. GHRP-2 has no FDA-approved label and is classified as an unapproved research compound. It has not been evaluated by regulators for safety or effectiveness in humans.
Available trial registries show no currently registered clinical trials for GHRP-2. This means there is no public trial record to reference for this compound at this time.
GHRP-2 is cataloged in chemical databases under PubChem CID 6918245. It has a molecular formula of C45H55N9O6 and a molecular weight of approximately 818.
There is no adverse event reporting data currently available for GHRP-2, so no side effect pattern can be summarized at this time.
GHRP-2 is an unapproved research compound without an FDA label, approved indications, or established use outside of research settings. No efficacy or safety claims can be made based on available data.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem CID 6918245
Updated 2026-11-07